Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Gene therapy/gene editing combo could offer hope for some genetic disorders
Newer Targets
AmorChem Invests in Novel Approach to Target Myc-driven Cancers
Newer Targets
Researchers at Rush University Medical Center Find That Injecting Influenza Vaccines…
Newer Targets
Research Reveals Promising New Avenues for Anemia Treatment
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Hansa Biopharma Announces Long Term Follow-up Data That Demonstrates 2-year Graft…
Approval
Allergan’s Durysta Implant Approved to Treat Glaucoma
Phase III
AstraZeneca Bladder Cancer Treatment Fails to Hit the Mark in Phase…
Approval
Novadoz Pharmaceuticals Increases Presence in the Generic Oncology Market with an…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
CEPI says funding gap of $2 billion could hamper COVID-19 vaccine…
Deals
AcelRx Announces Agreement for an Investigator-Initiated Study of DSUVIA in Patients…
Commercial
Seelos Therapeutics Receives Notice of Allowance for Composition of Matter Patent…
Deals
Announcement of Joint Research Agreement with Nagoya University for Spinal Cord…
Home
Clinical
Phase I
Phase I
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase I
Dynacure Announces First Patient Dosed in Phase 1 / 2 ‘UNITE-CNM’ Study of DYN101 for the Treatment of Myotubular and Centronuclear Myopathies (CNM)
Biospace News
-
March 5, 2020
Phase I
Zhimeng Biopharma Announces the First-in-Human Dosing in Phase I Clinical Trial of ZM-H1505R Designed for the Treatment of Chronic Hepatitis B Virus Infection
Phase I
Allergan, Editas dose first patient with CRISPR-based therapy AGN-151587 in Leber congenital amaurosis trial
Phase I
Allergan and Editas Medicine Announce Dosing of First Patient in Landmark Phase 1/2 Clinical Trial of CRISPR Medicine AGN-151587 (EDIT-101) for the Treatment of...
Phase I
Allergan and Editas Dose First Patient in Historic CRISPR Trial for Inherited Blindness
Phase I
PureTech Announces First Participant Dosed in Clinical Trial of Wholly-Owned Lymphedema...
Biospace News
-
March 3, 2020
0
Phase I
Ascentage Pharma Announces Approval for the Phase Ib/II Clinical Trial of...
Firstwordpharma News
-
February 24, 2020
0
Phase I
AGTC Announces Completion of Enrollment in the Two Highest Dose Groups...
Firstwordpharma News
-
February 19, 2020
0
Phase I
Terns Pharmaceuticals Announces Safety and Pharmacodynamic Results of a Phase 1...
Biospace News
-
February 19, 2020
0
Phase I
Atreca Announces First Patient Dosed in Phase 1b Clinical Trial of...
Firstwordpharma News
-
February 13, 2020
0
1
2
3
...
29
Page 1 of 29
- Advertisement -
MOST POPULAR
Antibe Therapeutics Reports 2019 Year-End Financial and Operating Results
July 17, 2019
FDA approves new treatment for adults with partial-onset seizures
November 21, 2019
Revance Announces U.S. FDA Acceptance of Biologics License Application (BLA) for...
February 6, 2020
Scottish Medicines Consortium rituximab (MabThera)
May 13, 2019
Load more
HOT NEWS
Commercial
Tip That Launched College Bribery Scandal Case Came From Pharma Pump-and-Dump...
Neurology
Calculated Percentage Pain-Reduction Scores Correlate Modestly With Those Reported by Patients...
Deals
Applied Biology to Enter into a License Agreement with Hairmore for...
Deals
Equillium & Biocon Expand Exclusive Licensing Agreement for Itolizumab to Include...
